Industrial Partners

Start-Up Culture

Voximetry is an early stage healthcare technology company that specializes in commercializing improvements related to nuclear medicine dosimetry. Voximetry’s patient-specific approach can accurately predict efficacy and adverse effects of radiopharmaceutical therapy, thereby improving patient outcomes. Prof. Bednarz along with two former RED Lab scientists, Joe Grudzinski and Paul Wickre, co-founded the company in 2016. Voximetry leverages intellectual property developed in the RED Lab at the University of Wisconsin – Madison, which has a rich history of fostering successful biotechnology companies. To date, the company has received +$2,500,000 in grant revenue and has hired 8 employees to develop their commercial software products. In 2019, the company received 2nd place in the Biotechnology division of the Wisconsin’s Governors Business Plan Competition. Voximetry’s novel dose calculation software Torch received FDA 510(K) clearance in 2022. For more information please visit the company’s website.